A Mathematical Model of the Enhancement of Tumor Vaccine Efficacy by Immunotherapy
- 22 March 2012
- journal article
- research article
- Published by Springer Nature in Bulletin of Mathematical Biology
- Vol. 74 (7) , 1485-1500
Abstract
TGF-β is an immunoregulatory protein that contributes to inadequate antitumor immune responses in cancer patients. Recent experimental data suggests that TGF-β inhibition alone, provides few clinical benefits, yet it can significantly amplify the anti-tumor immune response when combined with a tumor vaccine. We develop a mathematical model in order to gain insight into the cooperative interaction between anti-TGF-β and vaccine treatments. The mathematical model follows the dynamics of the tumor size, TGF-β concentration, activated cytotoxic effector cells, and regulatory T cells. Using numerical simulations and stability analysis, we study the following scenarios: a control case of no treatment, anti-TGF-β treatment, vaccine treatment, and combined anti-TGF-β vaccine treatments. We show that our model is capable of capturing the observed experimental results, and hence can be potentially used in designing future experiments involving this approach to immunotherapy.Keywords
This publication has 37 references indexed in Scilit:
- Emergent Group Dynamics Governed by Regulatory Cells Produce a Robust Primary T Cell ResponseBulletin of Mathematical Biology, 2009
- Synergistic Enhancement of CD8+ T Cell–Mediated Tumor Vaccine Efficacy by an Anti–Transforming Growth Factor-β Monoclonal AntibodyClinical Cancer Research, 2009
- Decoding the quantitative nature of TGF-β/Smad signalingTrends in Cell Biology, 2008
- Modeling regulation mechanisms in the immune systemJournal of Theoretical Biology, 2007
- Cancer Immunotherapy by Interleukin-21: Potential Treatment Strategies Evaluated in a Mathematical ModelCancer Research, 2006
- Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretationsJournal of Theoretical Biology, 2006
- A mathematical model of tumor-immune evasion and siRNA treatmentDiscrete and Continuous Dynamical Systems-Series B, 2004
- Estimating the Precursor Frequency of Naive Antigen-specific CD8 T CellsJournal of Experimental Medicine, 2002
- TGF- β signaling in cancer – a double-edged swordTrends in Cell Biology, 2001
- Commentary: Immunosuppression Mediated by Tumor Cells: A Challenge for Immunotherapeutic ApproachesHuman Gene Therapy, 2000